https://doi.org/10.31288/oftalmolzh201446670

Probability of optic neuropathy in patients with endocrine ophthalmopathy at the early stages of the diseases

Awis Kayali

State Institution The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine, Odessa, (Ukraine)

Key words. optic neuropathy, endocrine ophthalmopathy, assessment of the state

Importance. Development of optic neuropathy (ON) is found in 3—30 % of patients with endocrine ophthalmopathy (EOP) and in 70 % of patients with decompensated EOP. The diagnosis of ON is made in the late stages of the diseases when there are signs of edema or atrophy and visual functions are lost. Early diagnosis of ON in patients with EOP can allow to prevent loss of the visual functions and disability of patients. Purpose. To study probability of ON development in patients with EOP at the early stage of the disease.

Material and methods. The investigation was made on the basis of retrospective analysis of 332 case histories of patients with EOP (664 eyes) who were treated at SI» Filatov's Institute of eye diseases and tissue therapy of NAMS of Ukraine» from 2002 to 2013.

The biometric analysis was made using statistic pack Statistica 9.0.

Results. There was made a complex assessment of different clinical symptoms by their portion in occurrence in patients with EOP with manifestations of ON and without it. There were revealed most significant symptoms for development of ON in EOP and according to the data of one-variant logistic regression there was made a quantitative assessment of the degree of association of the studied clinical symptoms in development of ON making calculation of Odds Ratio. Conclusions. The diagnosis of the signs revealed at the early stages of the diseases will allow to reduce the risk of loss of visual functions by timely medicamentous therapy.

References

1.     Brovkina AF, Gusev GA, Panteleeva OG. Optic neuropathy in patients with edema exophthalmia. RMZh, Kliniches-kaia oftalmologiia. 2000;1(2):41-2. Russian.

2.     Rebrova OYu. Statistic analysis of medical data. Moscow: Media Sfera; 2002. 305 p.

3.     Yunkerov VI, Grigoriev SG. Mathematic and statistic data analysis of medical research. Saint Petersburg; 2002. 215 p.

4.     Acaroglu G, Simsek Т, Ozalp S, Mutluay A. Subclinical optic neuropathy in Graves' orbitopathy. Jpn. J. Ophthalmol. 2003;47(5):459-б2.
Crossref

5.     Bartalena L, Pinchera A, Marcocci C. Management of Graves' Ophthalmopathy: Reality and Perspectives. Endocrine Reviews. 2000;21(2):1б8-99.
Crossref

6.     Ben Simon GJ, Syed H, Douglas R et al. Clinical manifestations and treatment outcome of optic neuropathy in thyroid- related orbitopathy. Ophthalmic. Surg. Lasers Imaging. 200б;37(4):284- 90.
Crossref

7.     Lazarus JH, McKeag D, Lane C. Clinical Features of Dysthyroid Optic Neuropathy: A European Group on Graves' Orbitopathy (EUGOGO) Survey. Br. J. Ophthalmol. 200б, Oct 31.

8.     Giaconi JA, Kazim M, Rho T, Pfaff C. CT scan evidence of dysthyroid optic neuropathy. Ophthal. Plast. Reconstr. Surg. 2002;18(3):177- 82.
Crossref

9.     Korinth MC, Ince A, Banghard W, Gilsbach JM. Followup of extended pterional orbital decompression in severe Graves' ophthalmopathy. Acta Neuro- chir (Wien). 2002;144(2):113- 20.
Crossref

10.  Lane CM, Boschi A. Management of very several Graves' orbitopathy (Disthyroid optic neuropathy). In book: Graves' orbitopathy. A multidisciplinary approach. Ed. Wiersinga WM, Kahaly GJ, Karger. 2007. 153- 9.
Crossref

11.  Levy J, Sobel R, Marcus M, Lifshitz T. Thyroid ophthalmopathy. Minerva Endocrinol. 2005;30(4):247- 65.

12.  Mirkiewicz-Sieradzka B, Jakubowska B. Ophthalmologic aspects of treating optic neuropathy during the course of Graves-Basedow disease. Przegl. Lek. 2000;57(6):318- 20.

13.  Sun H, Jiao Q, Tan L et al. Thyroid-associated ophthalmopathy: a clinical study of 381 cases. Zhonghua Nei Ke Za Zhi. 2006;45(5):400- 2.